MELOXICAM

USDailyMed:Meloxicam AU:C M01AC06(WHO)M01AC56(WHO),N01BB59(WHO) AU:S4(Prescription only)CA:℞-onlyUK:POM(Prescription only)US:℞-onlyEU:Rx-only 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide 71125-38-7Y 5281106 7220 DB00814Y 10442740Y VG2QF83CGL D00969Y CHEBI:6741Y ChEMBL599Y MXM (PDBe,RCSB PDB) DTXSID1020803 Interactive image Cc1cnc(s1)NC(=O)C\3=C(/O)c2ccccc2S(=O)(=O)N/3C InChI=1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,18H,1-2H3,(H,15,16,19)YKey:ZRVUJXDFFKFLMG-UHFFF‍​‍‍‍​‍‍‍‍‍‍‍‍​‍AOYSA-NY Meloxicam, sold under the brand nameMobicamong others, is anonsteroidal anti-inflammatory drug(NSAID) used to treat pain and inflammation inrheumatic diseasesandosteoarthritis.It is taken by mouth or given byinjection into a vein.It is recommended that it be used for as short a period as possible and at a low dose. Common side effects include abdominal pain, dizziness, swelling, headache, and a rash.Serious side effects may includeheart disease,stroke, kidney problems, andstomach ulcers.Use is not recommended in thethird trimester of pregnancy.It blockscyclooxygenase-2(COX-2) more than it blockscyclooxygenase-1(COX-1).It is in theoxicamfamily of chemicals and is closely related topiroxicam. It is available as ageneric medication.In 2023, it was the 27th most commonly prescribed medication in the United States, with more than 20million prescriptions.An intravenous version of meloxicam (Anjeso) was approved for medical use in the United States in February 2020.Meloxicam is available in combination with bupivacaine asbupivacaine/meloxicamand in combination with rizatriptan asmeloxicam/rizatriptan.